RESTRICTED STOCK (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Stock Options And Restricted Stock
Non-cash compensation expense	$ 335,918	$ 529,795
Outstanding restricted stock grants		201,655
Weighted average grant date value		$ 9.74
Nonvested at end of period	47,958	47,958
Shares of non-vested restricted stock	201,655
Total unrecognized compensation expense		$ 121,000
FDA Approval [Member]
Stock Options And Restricted Stock
Restricted stock to vest upon FDA approval	14,185
One Year [Member]
Stock Options And Restricted Stock
Restricted stock to vest upon FDA approval	22,898
Four Years [Member]
Stock Options And Restricted Stock
Restricted stock to vest upon FDA approval	10,875